logo-loader
Instem PLC

Result of AGM

/**/ .o{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.o{}p.al{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height: normal; margin-bottom: 12.1pt; text-align: center}span.aj{color:black}p.am{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top: 0cm; text-align: center}span.an{color: black; font-family: "Calibri","sans-serif"; font-size: 11.0pt; font-weight: bold}p.ao{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;text-align:justify}span.ap{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}p.aq{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;text-align:justify;vertical-align:baseline}span.ar{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black} span.as{font-size:11.0pt; font-family:"Calibri","sans-serif";color:black}span.at{font-size:11.0pt;font-family: "Calibri","sans-serif";color:black}p.au{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 12.1pt; text-align: justify}table.av{width:468.0pt;margin-left:-21.6pt;border-collapse:collapse}td.x{width:209.15pt;padding:0cm 5.4pt 0cm 5.4pt}p.aw{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 12.1pt; margin-left: 5.4pt; margin-right: 0cm; margin-top: 0cm; text-align: justify}td.w{width:194.05pt;padding:0cm 5.4pt 0cm 5.4pt}p.ax{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:12.1pt; margin-left:5.4pt;text-align:justify;line-height:normal}p.ay{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:12.1pt;text-align:justify;line-height: normal}tr.q{height:26.3pt} td.s{width:209.15pt;padding:0cm 5.4pt 0cm 5.4pt; height:26.3pt}p.az{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:5.4pt;margin-bottom:.0001pt;text-align:justify;line-height:normal}td.r{width:194.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:26.3pt}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";}p.ba{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;text-align:justify}span.bb{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black} /**/
RNS Number : 0075A
Instem plc
23 May 2019
 

Instem plc
("Instem" or the "Company")

Result of AGM

 

Instem (AIM: INS.L), a leading provider of IT solutions to the global life sciences market, announces that at its Annual General Meeting held today, all resolutions were duly passed. 

For further information, please contact:

Instem plc

+44 (0) 1785 825 600

Phil Reason, CEO


Nigel Goldsmith, CFO




 

N+1 Singer (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000

Richard Lindley

Rachel Hayes




 

Walbrook Financial PR

 

+44 (0) 20 7933 8780

Paul Cornelius

[email protected]

Nick Rome

Sam Allen

 


 

About Instem 

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

 Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RAGSELFSDFUSEEI

Quick facts: Instem PLC

Price: £3.70

Market: AIM
Market Cap: £60.3 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Instem seeing all clients place orders as healthcare market stays buoyant

Phil Reason, chief executive of healthcare AI software group Instem PLC (LON:INS), says business was strong across all areas of the group in the first six months of 2019. Even a change from licences to a SaaS or pay-as you-use model has gone smoothly, he says, with cash inflows strong...

on 26/7/19